drugset / Trial / NCT02199652

Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD)

NCT02199652

Phase 4 Completed 20 enrolled Augusta University
RandomizedParallel-groupSingle-blindTreatment

Summary

Patients with PTSD, and frequent nightmares, and mild-moderate suicidal ideation, who are already taking a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) will be randomized to either prazosin or placebo. The investigators hypothesize that patients receiving prazosin will have a greater reduction in suicidal ideation.

Timeline

Start
2014-03
Primary completion
2017-09-01
Completion
2017-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Prazosin Unknown